METHODS:
Slices of articular cartilage from the different zones were isolated from adult bovine metacarpophalangeal joints. The chondrocytes were liberated from the slices by digestion with pronase (0.2%, 30 min.) followed by collagenase-P (0.025%, 16 hrs.). Some preparations of freshly isolated chondrocytes from both superficial and deep zones were biotinylated with sulfo-NHS-biotin at 4 0 C. The biotinylated cells were washed, and lysed by freezing. Slices of superficial and deep zone cartilage were also frozen and powdered in liquid nitrogen. In each case, insoluble material was recovered by centrifugation and sequentially extracted with 3 M urea, a neutral NP-40 buffer, and SDS-PAGE sample buffer. Likewise, insoluble material from the collagenase-P digestion media was recovered by ultracentrifugation. The amount of superficial and deep zone protein extract used in SDS-PAGE and on western blots was normalized to DNA or protein concentration. Protein in gel bands was digested by the endoproteinase lys-C. Peptides were separated by reverse phase HPLC and sequenced by Edman degradation. Polyclonal antibodies against Del1 were produced in New Zealand white rabbits with a KLH-synthetic peptide conjugate. Antibody specificity was determined by sequencing the antibody binding protein bands from western blots. Western blots were probed with streptavidin peroxidase, anti-Del1 polyclonal antibodies, or purified αvβ3 integrin. Isolated superficial and deep zone chondrocytes were also stained with ant-Del1 polyclonal antibodies.
RESULTS:
Chondrocytes liberated with pronase followed by collagenase-P yielded cells from the superficial zone with some residual cell-associated matrix, while deep zone cells retained little if any cell-associated matrix. A 43 kDa protein band was detected in NP-40 extracts of biotinylated superficial zone cells, but was absent from extracts of the deep zone cells. The 43 kDa band was excised from SDS-PAGE gels, and identified by protein sequencing as Del1. Antibodies generated against synthetic peptides from Del1 were used in western blots, and confirmed the presence of Del1 in extracts of the superficial zone. The most immunoreactivity was in the superficial zone NP-40 extract and in the insoluble material of the superficial zone collagenase-P digestion media. Anti-Del1 antibodies detected several bands between 43 and 66 kDa on western blots. Western blots normalized for either DNA or protein load confirmed the observation that Del1 was enriched in the superficial zone of articular cartilage. The enrichment of Del1 in the superficial zone was observed in both extracts from liberated chondrocytes or cartilage tissue slices (Fig. 1, lanes 2 and 4) . Extracts from cartilage tissue slices had an increased immunoreactivity in the upper (52 kDa) band when compared to extracts from pronase/collagenase isolated chondrocytes. This would be consistent with a greater content of intact Del1 protein. Purified αvβ3 integrin was biotinylated and bound to the Del1 bands on western blots. Immunocytochemistry showed the strongest reactivity on isolated superficial zone chondrocytes, with only a slight reactivity on isolated deep zone chondrocytes. The reactivity in isolated superficial zone chondrocytes appeared strongest in pericellular rings or patches, but was also detected throughout the residual cell-associated matrix up to the cell membrane.
DISCUSSION:
We report here the isolation of a new protein, Del1, in adult bovine articular cartilage. Using polyclonal antibodies against Del1 we produced, this protein appears to be enriched in the superficial zone of articular cartilage. Chondrocytes freshly isolated from the superficial zone of articular cartilage by a pronase/collagenase treatment retain a cell-associated matrix, and Del1 is a major component of this matrix. Del1 is a 52 kDa embryonic endothelial cell protein identified through an enhancer trap event in a transgenic mouse (4). The gene isolated encoded a protein, which contains three Notch-like epidermal growth factor repeats, an RGD motif, and two discoidin domains. Del1 is thought to be expressed in an endothelial cell restricted pattern during early development, and promote endothelial cell attachment and migration via the αvβ3 integrin. In two different assay systems, Del1 has been reported with both anti-angiogenic (4), and angiogenic (5) properties. Del1 is a ligand for the αvβ3 integrin on endothelial cells, and Del1 extracted from articular cartilage appears to be a ligand for this integrin as well. The αvβ3 integrin has been reported exclusively at the surface (30 µm) of human articular cartilage (6) . Binding the αvβ3 integrin may help retain Del1 in the superficial aspect of articular cartilage. Del1 is part of an enzyme-resistant cell-associated matrix around superficial zone chondrocytes which is absent from deep zone chondrocytes. This cell-associated matrix may enhance the protective function of the surface of articular cartilage by forming a special microenvironment around the superficial cells. The proteolytic resistance of parts of Del1 to pronase and crude bacterial collagenase digestion would be consistent with a protective function.
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